Dr Reddy secures USFDA approval for generic Zenatane capsules
The Company has launched the product following the approval.
New Delhi, March 29, 2013: Dr Reddy’s has launched the generic version of Zenatane capsules in the US market after securing the approval for the product from the US health and drug regulator. Dr Reddy’s said in a statement that the company has launched the generic Accutane (Isotretinoin Capsules USP) in the strengths of 20 mg and 40 mg on March 28 following the approval by the US Food & Drug Administration ( USFDA) of its abbreviated new drug application (ANDA) for the product in the strengths of 10 mg, 20 mg and 40 mg.
Established back in 1984, Dr Reddy’s today offers a wide portfolio of products in the active pharmaceutical ingredients (APIs), custom pharmaceutical services (CPS), generics, biosimilars, differentiated formulations and new chemical entities.